- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04277871
Effects of an Intervention on Improving Midlife Women's Menopause-related Symptoms
February 19, 2020 updated by: National Yang Ming University
This study was an experimental study with repeated measures.
Study aims were to examine the effects of pelvic floor muscles training (PFMT) combined with yoga on improving genitourinary/climacteric symptoms, the pelvic floor muscles strength, and health-related quality of life (HRQL).
Study participants were assigned to the intervention group or comparison group.
Data analyses were based on the information obtained from 91 midlife women with a mean age of 56.6 years.
Information related o the pelvic floor muscles strength was only obtained from 45 women.
Descriptive statistics were used to represent study participants' individual characteristics, genitourinary/climacteric symptoms, the pelvic floor muscles strength, and HRQL.
Paired t tests, independent t tests, and Generalized Estimating Equation (GEE) procedures were used to examine the intervention effects.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study was an experimental study with repeated measures.
Study aims were to examine the effects of PFMT combined with yoga on improving genitourinary/climacteric symptoms, the pelvic floor muscles strength, and HRQL.
Study participants were randomly assigned to the intervention group or comparison group.
All study participants received an educational section (a discussion section and an abbreviated practice section) and related educational materials.
The intervention group attended on-site group practice sessions and performed individual home-based practice.
The comparison group performed individual home-based practice only.
Data analyses were based on the information obtained from a sample of midlife women with a mean age of 56.6 years.
Relevant information was mainly collected by a structured questionnaire.
Information related to the pelvic floor muscles strength was only obtained from 45 women in the intervention group by using the FemiScan pelvic floor therapy system.
Descriptive statistics were used to represent study participants' individual characteristics, genitourinary/climacteric symptoms, the pelvic floor muscles strength, and HRQL.
Paired t tests, independent t tests, and GEE procedures were used to examine the intervention effects.
Study Type
Interventional
Enrollment (Actual)
91
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
47 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Women who experienced ≥1 genitourinary symptoms.
Exclusion Criteria:
- Being pregnancy or breastfeeding, experiencing iatrogenic menopause (e.g., surgery, chemotherapy or radiation related), maintaining regular PFMT and/or yoga practices, using oral contraceptive or psychiatric medications, and having physical weakness/limitation or major cognitive impairment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: The intervention group
The intervention group received an educational section and related educational materials.
The educational section involved two sub-sections: a discussion section and an abbreviated practice section.
The intervention group attended on-site group practice sections and performed individual home-based practice.
|
All study participants were instructed to perform PFMT combined with yoga with an expectation of performing a 70-minute practice section 3 days in a week.
All study participants received a booklet with menopause-related information, a booklet plus an instructional Digital Video Disc for PFMT and yoga practice.
|
|
Active Comparator: The comparison group
The comparison group received an educational section and related educational materials.
The educational section involved two sub-sections: a discussion section and an abbreviated practice section.
The comparison group performed individual home-based practice only.
|
All study participants were instructed to perform PFMT combined with yoga with an expectation of performing a 70-minute practice section 3 days in a week.
All study participants received a booklet with menopause-related information, a booklet plus an instructional Digital Video Disc for PFMT and yoga practice.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Genitourinary Symptoms
Time Frame: Baseline
|
Self-reporting 11 genitourinary symptoms: We generated three items to measure genital symptoms based on available information (The North American Menopause Society, 2013), and used the Lower Urinary Tract Symptoms (LUTS) subscale in the Taiwan Teacher Bladder Survey for measuring LUTS (Liao et al., 2006).
|
Baseline
|
|
Genitourinary Symptoms
Time Frame: 3-month follow-up
|
Self-reporting 11 genitourinary symptoms: We generated three items to measure genital symptoms based on available information (The North American Menopause Society, 2013), and used the Lower Urinary Tract Symptoms (LUTS) subscale in the Taiwan Teacher Bladder Survey for measuring LUTS (Liao et al., 2006).
|
3-month follow-up
|
|
Genitourinary Symptoms
Time Frame: 6-month follow-up
|
Self-reporting 11 genitourinary symptoms: We generated three items to measure genital symptoms based on available information (The North American Menopause Society, 2013), and used the Lower Urinary Tract Symptoms (LUTS) subscale in the Taiwan Teacher Bladder Survey for measuring LUTS (Liao et al., 2006).
|
6-month follow-up
|
|
Genitourinary Symptoms
Time Frame: 9-month follow-up
|
Self-reporting 11 genitourinary symptoms: We generated three items to measure genital symptoms based on available information (The North American Menopause Society, 2013), and used the Lower Urinary Tract Symptoms (LUTS) subscale in the Taiwan Teacher Bladder Survey for measuring LUTS (Liao et al., 2006).
|
9-month follow-up
|
|
Genitourinary Symptoms
Time Frame: 12-month follow-up
|
Self-reporting 11 genitourinary symptoms: We generated three items to measure genital symptoms based on available information (The North American Menopause Society, 2013), and used the Lower Urinary Tract Symptoms (LUTS) subscale in the Taiwan Teacher Bladder Survey for measuring LUTS (Liao et al., 2006).
|
12-month follow-up
|
|
Climacteric Symptoms
Time Frame: Baseline
|
Self-reporting 21 physical and psychological symptoms: We used the Taiwan-version of the Greene Climacteric Scale for measuring climacteric symptoms (Greene, 2008).
|
Baseline
|
|
Climacteric Symptoms
Time Frame: 3-month follow-up
|
Self-reporting 21 physical and psychological symptoms: We used the Taiwan-version of the Greene Climacteric Scale for measuring climacteric symptoms (Greene, 2008).
|
3-month follow-up
|
|
Climacteric Symptoms
Time Frame: 6-month follow-up
|
Self-reporting 21 physical and psychological symptoms: We used the Taiwan-version of the Greene Climacteric Scale for measuring climacteric symptoms (Greene, 2008).
|
6-month follow-up
|
|
Climacteric Symptoms
Time Frame: 9-month follow-up
|
Self-reporting 21 physical and psychological symptoms: We used the Taiwan-version of the Greene Climacteric Scale for measuring climacteric symptoms (Greene, 2008).
|
9-month follow-up
|
|
Climacteric Symptoms
Time Frame: 12-month follow-up
|
Self-reporting 21 physical and psychological symptoms: We used the Taiwan-version of the Greene Climacteric Scale for measuring climacteric symptoms (Greene, 2008).
|
12-month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Pelvic Floor Muscles Strength
Time Frame: Baseline
|
For the intervention group, we obtained the Pelvic Floor Muscles' perianal surface electromyography by using the FemiScan pelvic floor therapy system.
Two parameters (activity and peak; µV) resulted from the electromyography were used to represent the Pelvic Floor Muscles strength (Mega Electronics Ltd, 2002-2006).
|
Baseline
|
|
The Pelvic Floor Muscles Strength
Time Frame: 3-month follow-up
|
For the intervention group, we obtained the Pelvic Floor Muscles' perianal surface electromyography by using the FemiScan pelvic floor therapy system.
Two parameters (activity and peak; µV) resulted from the electromyography were used to represent the Pelvic Floor Muscles strength (Mega Electronics Ltd, 2002-2006) .
|
3-month follow-up
|
|
The Pelvic Floor Muscles Strength
Time Frame: 6-month follow-up
|
For the intervention group, we obtained the Pelvic Floor Muscles' perianal surface electromyography by using the FemiScan pelvic floor therapy system.
Two parameters (activity and peak; µV) resulted from the electromyography were used to represent the Pelvic Floor Muscles strength (Mega Electronics Ltd, 2002-2006).
|
6-month follow-up
|
|
The Pelvic Floor Muscles Strength
Time Frame: 9-month follow-up
|
For the intervention group, we obtained the Pelvic Floor Muscles' perianal surface electromyography by using the FemiScan pelvic floor therapy system.
Two parameters (activity and peak; µV) resulted from the electromyography were used to represent the Pelvic Floor Muscles strength (Mega Electronics Ltd, 2002-2006).
|
9-month follow-up
|
|
The Pelvic Floor Muscles Strength
Time Frame: 12-month follow-up
|
For the intervention group, we obtained the Pelvic Floor Muscles' perianal surface electromyography by using the FemiScan pelvic floor therapy system.
Two parameters (activity and peak; µV) resulted from the electromyography were used to represent the Pelvic Floor Muscles strength (Mega Electronics Ltd, 2002-2006).
|
12-month follow-up
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Health-related Quality of Life
Time Frame: Baseline
|
We used the Taiwan version of the Short Form-36 (SF-36) Health Survey to measure quality of life (Fuh et al., 2000).
|
Baseline
|
|
Health-related Quality of Life
Time Frame: 3-month follow-up
|
We used the Taiwan version of the Short Form-36 (SF-36) Health Survey to measure quality of life (Fuh et al., 2000).
|
3-month follow-up
|
|
Health-related Quality of Life
Time Frame: 6-month follow-up
|
We used the Taiwan version of the Short Form-36 (SF-36) Health Survey to measure quality of life (Fuh et al., 2000).
|
6-month follow-up
|
|
Health-related Quality of Life
Time Frame: 9-month follow-up
|
We used the Taiwan version of the Short Form-36 (SF-36) Health Survey to measure quality of life (Fuh et al., 2000).
|
9-month follow-up
|
|
Health-related Quality of Life
Time Frame: 12-month follow-up
|
We used the Taiwan version of the Short Form-36 (SF-36) Health Survey to measure quality of life (Fuh et al., 2000).
|
12-month follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Yuan-Mei Liao, PhD, National Yang-Ming University, Taiwan, R.O.C
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Dumoulin C, Cacciari LP, Hay-Smith EJC. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev. 2018 Oct 4;10(10):CD005654. doi: 10.1002/14651858.CD005654.pub4.
- Cramer H, Peng W, Lauche R. Yoga for menopausal symptoms-A systematic review and meta-analysis. Maturitas. 2018 Mar;109:13-25. doi: 10.1016/j.maturitas.2017.12.005. Epub 2017 Dec 6.
- Sha K, Palmer MH, Yeo S. Yoga's Biophysiological Effects on Lower Urinary Tract Symptoms: A Scoping Review. J Altern Complement Med. 2019 Mar;25(3):279-287. doi: 10.1089/acm.2018.0382. Epub 2019 Feb 8.
- Mercier J, Morin M, Zaki D, Reichetzer B, Lemieux MC, Khalife S, Dumoulin C. Pelvic floor muscle training as a treatment for genitourinary syndrome of menopause: A single-arm feasibility study. Maturitas. 2019 Jul;125:57-62. doi: 10.1016/j.maturitas.2019.03.002. Epub 2019 Mar 29.
- Kim GS, Kim EG, Shin KY, Choo HJ, Kim MJ. Combined pelvic muscle exercise and yoga program for urinary incontinence in middle-aged women. Jpn J Nurs Sci. 2015 Oct;12(4):330-9. doi: 10.1111/jjns.12072. Epub 2015 Feb 23.
- Greene JG. Constructing a standard climacteric scale. Maturitas. 2008 Sep-Oct;61(1-2):78-84. doi: 10.1016/j.maturitas.2008.09.011.
- Liao YM, Dougherty MC, Boyington AR, Lynn MR, Palmer MH. Developing and validating a Chinese instrument to measure lower urinary tract symptoms among employed women in Taiwan. Nurs Outlook. 2006 Nov-Dec;54(6):353-61. doi: 10.1016/j.outlook.2006.09.003.
- Fuh JL, Wang SJ, Lu SR, Juang KD, Lee SJ. Psychometric evaluation of a Chinese (Taiwanese) version of the SF-36 health survey amongst middle-aged women from a rural community. Qual Life Res. 2000;9(6):675-83. doi: 10.1023/a:1008993821633.
- Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause. 2013 Sep;20(9):888-902; quiz 903-4. doi: 10.1097/GME.0b013e3182a122c2.
- Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Am J Obstet Gynecol. 2002 Jul;187(1):116-26. doi: 10.1067/mob.2002.125704. No abstract available.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2009
Primary Completion (Actual)
October 1, 2011
Study Completion (Actual)
January 1, 2012
Study Registration Dates
First Submitted
February 17, 2020
First Submitted That Met QC Criteria
February 19, 2020
First Posted (Actual)
February 20, 2020
Study Record Updates
Last Update Posted (Actual)
February 20, 2020
Last Update Submitted That Met QC Criteria
February 19, 2020
Last Verified
February 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- 97-2314-B-038-039
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Genitourinary Symptoms
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruitingGenitourinary Syndrome of Menopause
-
Żelazna Medical Centre, LLCLaboratory of Genetics and Human Genomics, University of GdańskCompleted
-
Tongji HospitalNot yet recruitingGenitourinary Syndrome of Menopause (GSM)China
-
59th Medical WingCompletedGenitourinary SymptomsUnited States
-
University of California, IrvineNational Institute for Biomedical Imaging and Bioengineering (NIBIB); Alma...Recruiting
-
University of California, IrvineNational Institutes of Health (NIH)Active, not recruitingGenitourinary Syndrome of MenopauseUnited States
-
Michigan Institution of Women's Health PCCompletedGenitourinary Syndrome of MenopauseUnited States
-
Korea UniversityCompletedDiseases of the Genitourinary SystemSouth Korea
-
Duke UniversityWallace H. Coulter FoundationCompletedCancer of the Gastrointestinal, Genitourinary or Gynecologic SystemsUnited States
-
Quanta System, S.p.A.Unknown
Clinical Trials on Pelvic floor muscles training (PFMT) combined with yoga
-
Universidade Federal de Sao CarlosUnknown
-
Ondokuz Mayıs UniversityThe Scientific and Technological Research Council of TurkeyCompletedMultiple Sclerosis | Lower Urinary Track Symptoms | Pelvic Floor Disorder | Women With Multiple SclerosisTurkey (Türkiye)
-
National Yang Ming Chiao Tung UniversityEnrolling by invitationQuality of Life | Genitourinary Symptoms | Sexual FunctionTaiwan
-
Pavol Jozef Safarik UniversityCompletedStress Urinary IncontinenceSlovakia
-
Glasgow Caledonian UniversityNHS Greater Glasgow and ClydeCompletedPelvic Organ ProlapseUnited Kingdom
-
Tanta UniversityRecruitingChildren | Biofeedback | Dysfunctional Voiding | Medical TreatmentEgypt
-
Norwegian University of Science and TechnologySt. Olavs Hospital; Norwegian Fund for Postgraduate Training in Physiotherapy; Fund for Cancer ResearchCompletedUrinary IncontinenceNorway
-
Hospital de Clinicas de Porto AlegreWithdrawn
-
University Hospital Plymouth NHS TrustCompletedBehaviouralUnited Kingdom
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloTerminatedUrologic Diseases | Prostate CancerBrazil